Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Gelder

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Transplantation|August 5, 2000
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reductionP J Smak Gregoor, T van Gelder, N M van Besouw, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional studyP J Smak Gregoor, T van Gelder, C J Hesse, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 6, 2003
[Twenty-five years of cyclosporin use in transplantation medicine]D A Hesselink, P M van Hagen, A H M M Balk, et al.
Transplantation Proceedings|September 18, 1997
Intragraft cytokine and growth factor mRNA expression in relation to graft vascular disease after heart transplantationC C Baan, C T Holweg, H G Niesters, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1995
Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipientsT van Gelder, A H Mulder, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
The TNF-alpha system after successful living-related kidney transplantationI C van Riemsdijk-van Overbeeke, C C Baan, E H Loonen, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 25, 2016
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerationsJ T Tang, L M Andrews, T van Gelder, et al.
Transplantation|August 15, 2001
Proteinuria after renal transplantation affects not only graft survival but also patient survivalJ I Roodnat, P G Mulder, J Rischen-Vos, et al.
Thrombosis Research|December 7, 2024
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding complications in the NetherlandsE M Appelman, E S L Martens, D M Burger, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Donor-specific CTL frequencies in peripheral blood in relation to graft vascular disease after clinical heart transplantationN M van Besouw, C R Daane, P de Kuiper, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Transplantation|August 5, 2000
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reductionP J Smak Gregoor, T van Gelder, N M van Besouw, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 1999
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional studyP J Smak Gregoor, T van Gelder, C J Hesse, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 6, 2003
[Twenty-five years of cyclosporin use in transplantation medicine]D A Hesselink, P M van Hagen, A H M M Balk, et al.
Transplantation Proceedings|September 18, 1997
Intragraft cytokine and growth factor mRNA expression in relation to graft vascular disease after heart transplantationC C Baan, C T Holweg, H G Niesters, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1995
Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipientsT van Gelder, A H Mulder, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
The TNF-alpha system after successful living-related kidney transplantationI C van Riemsdijk-van Overbeeke, C C Baan, E H Loonen, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 25, 2016
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerationsJ T Tang, L M Andrews, T van Gelder, et al.
Transplantation|August 15, 2001
Proteinuria after renal transplantation affects not only graft survival but also patient survivalJ I Roodnat, P G Mulder, J Rischen-Vos, et al.
Thrombosis Research|December 7, 2024
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding complications in the NetherlandsE M Appelman, E S L Martens, D M Burger, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Donor-specific CTL frequencies in peripheral blood in relation to graft vascular disease after clinical heart transplantationN M van Besouw, C R Daane, P de Kuiper, et al.
Pageof 17